Founded in 1913, City of Hope is an independent biomedical research and treatment organization for cancer, diabetes and other life-threatening diseases. They are a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. Their translational research and personalized treatment protocols advance care throughout the world. They have developed technology for breakthrough cancer drugs, human synthetic insulin, and monoclonal antibodies. AccessHope™, a subsidiary launched in 2019, provides specialized cancer expertise to employers and their health care partners. They are a National Cancer Institute-designated comprehensive cancer center and ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report.